TERE1 protein levels were assessed in two additional well-studied prostate cancer cell lines originally derived from metastases, DUI45 and PC3, to see if reduced levels of TERE1 in cell lines might be a feature in common with some metastatic prostate cancer specimens. This evidence concerns the gene UBIAD1 and prostate carcinoma.